Bastid
PHARMA-
PHARNEXT
France
Biography
More than 25 years in senior executive positions at major international business groups such as Schlumberger, Schneider Electric, Valeo and Thomson. Former President and CEO of Converteam Group, acquired from Alstom, he developed and sold to General Electric after the value increased by 30. His fund ZAKA has especially invested in several biotechnology companies including Carmat and Cellectis of which he is Board member.
Research Interest
pharma
